CN109355265A - A kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) and its application and encoding gene - Google Patents

A kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) and its application and encoding gene Download PDF

Info

Publication number
CN109355265A
CN109355265A CN201811412383.8A CN201811412383A CN109355265A CN 109355265 A CN109355265 A CN 109355265A CN 201811412383 A CN201811412383 A CN 201811412383A CN 109355265 A CN109355265 A CN 109355265A
Authority
CN
China
Prior art keywords
accr
enzyme
carbonyl
mut
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811412383.8A
Other languages
Chinese (zh)
Other versions
CN109355265B (en
Inventor
娄文勇
魏萍
宗敏华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN201811412383.8A priority Critical patent/CN109355265B/en
Publication of CN109355265A publication Critical patent/CN109355265A/en
Application granted granted Critical
Publication of CN109355265B publication Critical patent/CN109355265B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01184Carbonyl reductase (NADPH) (1.1.1.184)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides a kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) and its application and encoding gene.Carbonyl reductase AcCR can be catalyzed a variety of latent chiral carbonyl compounds asymmetric reductions, but it is lower for the activity and substrate tolerance of aromatic compound, the present invention is mutated using enzyme molecule transformation means by reductase AcCR is glycosylated, it obtains mutant mut-AcCR (I147V/G152L), mutant for 2- hydroxy acetophenone specific enzyme activity up to 6.4 U/mg, the Rate activity than unmutated preceding carbonyl reductase improves 17.4 times.Substrate tolerable concentration is improved from 50 mmol/L to 200 mmol/L.Carbonyl reduction enzyme mutant of the present invention is widely used in the asymmetric reduction of carbonyls.

Description

A kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) and its application with Encoding gene
Technical field
The invention belongs to enzyme molecules, and field is transformed, and in particular to a kind of carbonyl reduction enzyme mutant mut-AcCR (I144V/ G152L) and its application with encode the mutant gene.
Background technique
Optically pure chiral alcohol and its derivative are the important hands of synthesis of chiral drug, liquid crystal material, flavors and fragrances, pesticide Property intermediate, medicine and other chemical fields occupy critical positions.Chiral alcohol can be synthesized by chemical method and with bioanalysis. Chemical synthesis generally requires the harsh condition such as high temperature and pressure;Using a large amount of organic reagent, environmental pollution is serious;It prepared Journey is complicated, often there is repeatedly protection and deprotection step;The enantioselectivity for the product that more importantly chemical method obtains Property is low.Compared to chemical method, bioanalysis generally reacts at normal temperatures and pressures, and mild condition, equipment requirement is low, and environmental pollution is small, The advantages that Substratspezifitaet is strong, stereoselectivity and regioselectivity with higher, product enantiomeric purity is high.Biocatalysis Synthesis of chiral alcohol in strong momentum in medicine preparation mesosome to play an increasingly important role.Based on Green Chemistry With the principle of sustainable development, it is not only green but also sustainable route of synthesis that biocatalysis, which prepares chiral alcohol,.
Carbonyl reductase is as a kind of efficient, highly selective biocatalyst that can be used for asymmetric reduction reaction, often It is used to prepare chipal compounds with optical activation.Carbonyl reductase is great there are two when catalytic asymmetric reduction is reacted The problem of challenge, and limit it and further apply asymmetric catalysis synthesis.First, the latent hand of many high value chiral alcohols The dissolubility of property substrate is very low or is insoluble in the crude media of enzyme.This disadvantage can improve substrate by using non-aqueous media The method of solubility is addressed, such as uses organic solvent, ionic liquid, the single or double phase reaction medium of supercritical carbon dioxide Carry out biocatalytic reaction.A part of carbonyl reductase is also shown higher using these solvents as medium in high concentration of substrate Enzyme activity.But activity, selectivity and the stability of some carbonyl reductases often will appear in various degree in non-aqueous media Reduction.Therefore, it needs to screen reaction medium when selecting carbonyl reductase non-aqueous reaction medium.Second, due to carbonyl Base reductase has the characteristics that being not suitable with for stringent substrate specificity, coenzyme dependence and physiological environment, makes carbonyl reduction Enzyme can not effectively complete a specific Stereospecific synthesis reaction, such as in high concentration substrate, high temperature, extreme pH Under environment, carbonyl reductase often shows the deficiencies of activity is low, selectivity and stability are poor.
With the development of genomics and proteomics, scientist puts into more sight in protein engineering. Based on directed evolution and design and rational etc., protein sequence is modified, changes its structure, and then influences its catalytic Can, better regio- and stereo-selectivity, higher stability and substrate tolerance are made it have, is provided for the synthesis of chiral alcohol More efficient way.Protein engineering is preferably applied for enzyme molecule transformation, the biology leading with enzyme or cell can be made Catalysis is further developed in terms of other in substrate, medium, reactor etc., and the achievement for obtaining protein engineering obtains more Effectively, it more routinely applies.
In this seminar early-stage study, the clonal expression one from acetobacter Acetobacter sp.CCTCC M209061 Kind carbonyl reductase.The carbonyl reductase can be catalyzed a variety of substrates and carry out asymmetric reduction reaction, have good three-dimensional choosing Selecting property.But the carbonyl reductase is lower for the enzyme activity of the carbonyls such as 2- hydroxy acetophenone, for the resistance to of this kind of substrate It is poor by property, it only can be only achieved good catalytic effect when concentration of substrate is lower.
Summary of the invention
In order to overcome the disadvantage that the enzyme activity is low and substrate tolerance is poor, the primary purpose of the present invention is that providing a kind of work The carbonyl reduction enzyme mutant mut-AcCR (I147V/ for following trans- Prelog rule that property and substrate tolerance are significantly improved G152L)。
It is another object of the present invention to provide above-mentioned carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) Gene and amino acid sequence.
It is yet a further object of the present invention to provide above-mentioned carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) Using.
The purpose of the present invention is achieved through the following technical solutions.
A kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L), amino acid sequence such as SEQ ID NO.1 institute Show.
The present invention also provides the gene for encoding above-mentioned carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L), Gene order is as shown in SEQ ID NO.2.
Further, a kind of above-mentioned carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) is that reduction will be carbonylated Enzyme AcCR obtains carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) by the means that enzyme molecule is mutated.
Further, the gene order of AcCR is translated into its amino acid sequence by standard method, with the sequence in PDB It is searched in database, chooses 4RF2,1ZJY, 1NXQ and 1ZK3 three-level knot that homology is respectively 53%, 51%, 51% and 51% Structure is template, carries out homologous modeling, and carry out energy minimum, obtains the tertiary structure model of carbonyl reductase AcCR.Into One step is using ramachandran map Ramachandran (Ramachandran Plot) and Profile-3D to each amino acid residue in homologous modeling result The matching degree of reasonable structure and built protein model and protein amino acid sequence is assessed.Determine that model built is reasonable, It can be used for subsequent experimental analysis.
Further, carbonyl reductase AcCR tertiary structure is docked with coenzyme NAD H, it is pre- by HotSpot 2.0 The mutantional hotspot of carbonyl reductase is surveyed, chooses the site 147I and 152G as mutational site.
Further, the variation between mutation front and back carbonyl reductase and 2- hydroxy acetophenone is analyzed by molecular docking. Carbonyl reductase AcCR, mutant mut-AcCR (I147V/G152L) and 2- hydroxy acetophenone are subjected to molecular docking respectively, point Analysis enzyme active sites Ser142, Tyr155 and coenzyme NAD H niacinamide ring C4 be located at substrate to distance between 2- hydroxy acetophenone and The variation of active force.
Further, the activity of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) is measured, carbonyl reduction is measured The zymologic property of enzyme mutant mut-AcCR (I147V/G152L), studies mutant mut-AcCR by way of enzyme activity determination (I147V/G152L) optimum temperature and pH and stability.
The present invention also provides a kind of above-mentioned carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) in catalysis of carbonyl Application in the asymmetric reduction of compound.
Compared with prior art, the invention has the advantages that and the utility model has the advantages that a kind of carbonyl reduction provided by the invention Enzyme mutant mut-AcCR (I147V/G152L), overcomes that original carbonyl reductase enzyme activity is low and what substrate tolerance was poor lacks Point, enzyme activity and substrate tolerance with higher.
Detailed description of the invention
Fig. 1 a, Fig. 1 b are that AcCR and mut-AcCR and 2- hydroxy acetophenone dock comparative result figure;
Fig. 2 a, Fig. 2 b are influence comparison diagram of the temperature to mutant mut-I147V/G152L Activity and stabill;
Fig. 3 a, Fig. 3 b are influence comparison diagram of the pH of buffer to mutant mut-I147V/G152L Activity and stabill.
Specific embodiment
Below with reference to embodiment and attached drawing, the present invention is described in further detail, but embodiments of the present invention are unlimited In this.It is that those skilled in the art can refer to prior art reality if place is not described in detail especially it need to be pointed out that having below It is existing or understanding.
Embodiment 1
The gene order of AcCR is translated into its amino acid sequence by standard method, with the sequence in PDB database Search, choosing 4RF2,1ZJY, 1NXQ and 1ZK3 tertiary structure that homology is respectively 53%, 51%, 51% and 51% is mould Plate carries out homologous modeling, and carries out energy minimum, obtains the tertiary structure model of carbonyl reductase AcCR.Further adopt Each amino acid residue structure in homologous modeling result is closed with ramachandran map Ramachandran (Ramachandran Plot) and Profile-3D Rationality and the matching degree of built protein model and protein amino acid sequence are assessed.It determines that model built is reasonable, can be used for Subsequent experimental analysis.Carbonyl reductase AcCR tertiary structure is docked with coenzyme NAD H, carbonyl is predicted by HotSpot2.0 The mutantional hotspot of base reductase, the site 147I and 152G is as mutational site.
Embodiment 2
The variation between mutation front and back carbonyl reductase and 2- hydroxy acetophenone is analyzed by molecular docking;Respectively by carbonyl Reductase AcCR, mutant mut-AcCR (I147V/G152L) are docked with 2- hydroxy acetophenone, analyze enzyme active sites Ser142, Tyr155 and coenzyme NAD H niacinamide ring C4 are located at change of the substrate to distance and active force between 2- hydroxy acetophenone Change.AcCR shown in Fig. 1 a, Fig. 1 b and mut-E144A/G152L docks result figure with 2- hydroxy acetophenone.A, b is followed successively by 2- hydroxyl Benzoylformaldoxime docks result with AcCR, mut-I147V/G152L.It can be seen that catalytic site S142 after being mutated from Fig. 1 a, Fig. 1 b With 4, NADH niacinamide ring on hydrogen atom and the distance between the carbonylic oxygen atoms of 4 '-chloro-acetophenones reduce obvious, contract respectively It is short(20.1%) and(7.1%).These results suggest that the reduction of distance, the hydrogen bond for enhancing enzyme molecule and HAP is made With increasing stability of the enzyme in conjunction with HAP, improve the efficiency that C4 hydrogen atoms of NADH niacinamide ring are transmitted to substrate. Mut-I147V/G152L is 6.4U/mg for the enzyme activity of 2- hydroxy acetophenone, is AcCR enzyme activity (0.37U/mg) before being mutated 17.4 times.
Embodiment 3
Using PrimeSTAR Max DNA Polymerase, obtained by the method for carrying out the full plasmid amplification of pGEX-accr Obtain the plasmid pGEX-mut-I147V/G152L containing mutant mut-AcCR (I147V/G152L) gene.
Rite-directed mutagenesis the primer: the mutant primer of site I1447 is Primer1:5'- ACTGGTAGGGGACCCAATGGGAGCCG-3';Primer2:5'-CGGCCCTCATTGGG TCCCCTACCAGT-3';Site The mutant primer of G152L is Primer 3:5'-ACCCAATGTTGGC CGCCTATAAC-3', Primer 4:5'- GTTATAGGCGGCCAACATTGGGT-3'。
PCR amplification system and reaction condition used by rite-directed mutagenesis are as follows:
Polymerase chain reaction (PCR) amplification system
PCR reaction condition:
After reaction, reaction product is handled with restriction enzyme DpnI, acts on the site Gm6A^TC, disappears Template plasmid in change system.Reaction system are as follows:
Prepared endonuclease reaction system is placed at 37 DEG C and is incubated for 15min, that is, completes the digestion process of template plasmid.It will Digestion products directly convert bacillus coli DH 5 alpha.Positive transformant is verified using bacterium colony PCR, plasmid is extracted, is sequenced.
It is extracted from recombinant bacterium DH5 α (pGEX-mut-I147V/G152L) in the present invention and correct recombinant plasmid is sequenced PGEX-mut-I147V/G152L, and be transformed into E. coli expression strains BL21 (DE3), obtain recombinant strains BL21(DE3)(pGEX-mut-I147V/G152L)。
Embodiment 4
Picking contains the positive transformant of the BL21 (DE3) of mutant in LB culture medium of the 4mL containing 100 μ g/mL ammonia benzyls, It is incubated overnight under the conditions of 37 DEG C, 180r/min, 1mL culture solution is taken to be forwarded to the LB culture medium that 50mL contains 100 μ g/mL ammonia benzyls In, 37 DEG C, 180r/min cultivates to OD600To about 1.2, it will be added final concentration 0.4mmol/L's after near 20 DEG C of cultivation temperature IPTG cultivates 15-18h, 4 DEG C, 8000r/min centrifugation 5min collection thallus.4 DEG C, 8000r/min centrifugation 5min, remove supernatant Thallus is weighed afterwards three times with 0.85% brine, is dispersed in phosphate buffer (50mmol/L, pH by liquid 6.5) in, be configured to 30mg/mL cell suspending liquid, be placed in 4 DEG C it is spare.Using Ultrasonic Cell Disruptor smudge cells, Ultrasonic Cell Disruptor It is set as power 350W, work 3s, interval 5s, and ultrasonic time is set as 20min, and entire shattering process cell suspension is in always In ice-water bath, low temperature environment is kept to inactivate enzyme denaturation in order to avoid temperature is excessively high.After ultrasonication, broken suspension is placed in In centrifuge, 4 DEG C, 8000r/min centrifugation 30min, gained supernatant is the thick zyme extract for recombinating carbonyl reductase.
Using Bio-Rad NGC QuestTM10 mesohigh tomographic systems carry out recombination carbonyl reductase crude enzyme liquid pure Change.By the crude enzyme liquid of extraction with 0.22 μm of membrane filtration be placed on 4 DEG C it is spare.The general step of purifying are as follows: with 5 times of column volumes Buffer A(4.3mM Na2HPO4, 1.47mM KH2PO4, 137mM NaCl, 2.7mM KCl, pH7.3) and pre-equilibrate Bio- Scale Mini Profinity GST prepacked column (5mL, protein load amount 500mg), flow velocity 5mL/min;After pre-equilibration Start loading, using pump loading, flow velocity 1mL/min, applied sample amount about 500mg albumen;After end of the sample, continue flat with Buffer A The pillar that weighs is suitable with base line is pre-equilibrated to baseline;Then, with Buffer B (4.3mmol/L Na2HPO4, 1.47mM KH2PO4, 637mM NaCl, 2.7mM KCl, pH7.3) continue to rinse pillar, remove more firm foreign protein;Finally, with washing De- buffer solution B uffer C (50mM Tris-HCl, 2.5g/L glutathione, pH 8.0) wash-out recombinant protein AcCR, is washed De- obtained solution is the single recombinant protein A cCR after isolating and purifying.By there are also the eluents of recombinant protein A cCR to be placed in It analyses in bag, with PEG 20000, is concentrated in 4 DEG C of environment, the recombination enzyme solutions after concentration are saved in 4 DEG C.
Recombinate the determination condition of carbonyl reductase AcCR reduction activation: 0.25mmol/L NADH, 2mL phosphate buffer Appropriate enzyme solution is added in (50mmol/L, pH 6.5), 20mmol/L2- hydroxy acetophenone, 35 DEG C of incubation 5min, detects reaction system Under 340nm ultraviolet wavelength, the variation of light absorption value in 3min.
Enzyme activity definition: under the above conditions, the enzyme activity of 1 μm of ol NADH of catalysis oxidation per minute is 1 enzyme activity list Position, is indicated with U.
The calculation formula of enzyme activity is as follows:
Enzyme activity (U)=EW × V × 103/(6220×1)
In EW:1min at 340nm absorbance value variable quantity;V: the total volume of reaction solution, mL;6220: Molar Extinction system Number, L/mol/cm;1: optical path length, cm.
The enzyme activity determination of carbonyl reductase different mutants mut-AcCR the results are shown in Table 1.
The 1. carbonyl reduction enzyme mutant of table of comparison before and after to(for) different substrate actives
Embodiment 5
The optimum temperature and pH and steady of mutant mut-AcCR (I147V/G152L) are studied by way of enzyme activity determination It is qualitative.The optimal reactive temperature for recombinating carbonyl reductase AcCR is determined by the enzyme activity of enzyme when measurement different temperatures, that is, is divided Not at 25,30,35,40,45 DEG C, the enzyme activity of reference standard method measurement recombination carbonyl reductase AcCR.The thermostabilization of the enzyme Property measurement, i.e., the enzyme is placed in (25-45 DEG C) incubation 36h of different temperature, timing sampling measures the enzyme not according to standard method With the enzyme activity at time point.The vigor of the enzyme before being incubated for is set as 100% opposite enzyme activity.The reaction of each temperature is arranged two and puts down Row.As a result see Fig. 2 a, Fig. 2 b.Using 2- hydroxy acetophenone as substrate, influence of the temperature to the mutant is studied, finds the enzyme in institute Enzyme activity enzyme activity at 70% or more, 35 DEG C is preferably embodied in examination range, and 30 DEG C and 40 DEG C of enzyme activities are respectively 95% With 98% or so.Therefore, at 30-40 DEG C, enzyme activity can be obtained well to be showed the enzyme, carries out enzymic catalytic reaction ratio in the range Conveniently.Hydrophobic effect is the principal element for stablizing albumen natural structure.Val ratio Ile has stronger hydrophobic effect, more favorably In the stability for improving albumen.The enzyme has good thermal stability, within the scope of 30-40 DEG C, is incubated for 12h, opposite enzyme activity is still It is able to maintain 70% or more, thermal stability is better than unmutated AcCR.
Embodiment 6
The enzyme activity of the enzyme determines when recombinating the optimal reaction pH of carbonyl reductase AcCR by measuring different pH, that is, distinguishes In pH 5.0 to 8.0, the enzyme activity of reference standard method measurement recombination carbonyl reductase AcCR.The pH Stability Determination of the enzyme, Will the enzyme be placed in 4 DEG C, (5.0-7.0) is incubated for 96h within the scope of different pH, and timing sampling measures the enzyme according to standard method The enzyme activity of different time points.The enzyme activity of the enzyme before being incubated for is set as 100%.Each pH value is arranged two in parallel.Knot Fruit sees Fig. 3 a, Fig. 3 b.Influence discovery of the pH to mutant mut-I147V/G152L is studied, using 2- hydroxy-acetophenone as substrate When, which has 80% or more relative activity in pH 5.0-7.0;PH is greater than after 7.0, and enzymatic activity significantly reduces; PH mutation enzyme activity in 6.0-6.5 obtains maximum embodiment.The thermostabilization of the mutant enzyme is studied within the scope of pH5.0-7.0 Property, after pH is saved for 24 hours in 5.0-5.5, relative activity retains between 65%-80%;PH is in 6.0-7.0, thermostabilization Property it is more preferable, relative activity is retained in 95% or more, therefore the mutant has good pH stability.
Embodiment 7
Carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) is catalyzed the determination of activity of different substrates: 2mL is contained The phosphate buffer (100mmol/L, pH 6.5) of different substrates (20mmol/L) is added separately to make marks corresponding In 10mL triangular flask, in duplicate, 35 DEG C of incubation 10min, then a certain amount of AcCR mutant after purification, then, reference Standard method measures the enzyme to the enzyme activity of different substrates, using the enzyme to the enzyme activity of 2- hydroxy acetophenone as the enzyme 100% opposite enzyme activity.It the results are shown in Table 1.Mutant mut-I147V/G152L is other than improving 17.4 times to HAP enzyme activity, to being ground The catalytic activity for a variety of substrates studied carefully is significantly improved, for the enzyme activity of straight chain 'beta '-ketoester have 3.0-7.77 times not With the raising of degree.
2. carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) of table is catalyzed the asymmetry of latent chiral carbonyl compounds Reduction
E.e: enantiomeric excess value
Carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) is catalyzed the yield and enantio-selectivity of different substrates Measurement: 2mL is contained to the phosphate-buffered of different substrates (200mmol/L), 0.1mmol/L NADH and 400mmol/L isopropanol In liquid (100mmol/L, pH 6.5), it is added separately in the corresponding 10mL triangular flask to have made marks, in duplicate.35 DEG C be incubated for 10min after, a certain amount of AcCR mutant.Reaction flask is placed in 35 DEG C of gas bath constant temperature oscillators and is reacted (200rpm), 25 μ L of timing sampling are analyzed for GC or HPLC.It the results are shown in Table 2.The result shows that tolerance of the mutant enzyme for substrate Property and catalysis reaction yield have significantly improve.Under the concentration of substrate of 200mmol/L, mutant purifies 2- hydroxy acetophenone The products collection efficiency of generation is improved by unmutated preceding 50.62% (50mmol/L substrate) to (200mmol/L substrate) 90.5%, is improved 34.3%;The yield of catalysis ethyl acetoacetate asymmetric reduction is improved to 97.4%;It is catalyzed acetophenone asymmetric reduction Yield is improved to 76.8%, improves 31.8% compared with the yield of the unmutated enzymatic reaction.
Sequence table
<110>South China Science & Engineering University
<120>a kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) and its application and encoding gene
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 252
<212> PRT
<213>carbonyl reduction enzyme mutant (mut-AcCR (I147V/G152L))
<400> 1
Met Thr Arg Val Ala Gly Lys Val Ala Ile Val Ser Gly Ala Ala Asn
1 5 10 15
Gly Ile Gly Lys Ala Thr Ala Gln Leu Leu Ala Lys Glu Gly Ala Lys
20 25 30
Val Val Ile Gly Asp Leu Lys Glu Glu Asp Gly Gln Lys Ala Val Ala
35 40 45
Glu Ile Lys Ala Ala Gly Gly Glu Ala Ala Phe Val Lys Leu Asn Val
50 55 60
Thr Asp Glu Ala Ala Trp Lys Ala Ala Ile Glu Gln Thr Leu Lys Leu
65 70 75 80
Tyr Gly Arg Leu Asp Ile Ala Val Asn Asn Ala Gly Ile Ala Tyr Ser
85 90 95
Gly Ser Val Glu Ser Thr Ser Leu Glu Asp Trp Arg Arg Val Gln Ser
100 105 110
Ile Asn Leu Asp Gly Val Phe Leu Gly Thr Gln Val Ala Ile Glu Ala
115 120 125
Met Lys Lys Ser Gly Gly Gly Ser Ile Val Asn Leu Ser Ser Glu Gly
130 135 140
Leu Val Gly Asp Pro Met Leu Ala Ala Tyr Asn Ala Ser Lys Gly Gly
145 150 155 160
Val Arg Leu Phe Thr Lys Ser Ala Ala Leu His Cys Ala Lys Ser Gly
165 170 175
Tyr Lys Ile Arg Val Asn Ser Val His Pro Gly Tyr Ile Trp Thr Pro
180 185 190
Met Val Ala Gly Leu Thr Lys Glu Asp Ala Ala Ala Arg Gln Lys Leu
195 200 205
Val Asp Leu His Pro Ile Gly His Leu Gly Glu Pro Asn Asp Ile Ala
210 215 220
Tyr Gly Ile Leu Tyr Leu Ala Ser Asp Glu Ser Lys Phe Val Thr Gly
225 230 235 240
Ser Glu Leu Val Ile Asp Gly Gly Tyr Thr Ala Gln
245 250
<210> 2
<211> 762
<212> DNA
<213>carbonyl reduction enzyme mutant (mut-AcCR (I147V/G152L))
<400> 2
atgacacgtg tagcaggcaa ggttgccatt gtttctgggg ccgctaatgg cattggcaag 60
gcaaccgcac agcttttggc caaggaaggc gcaaaagttg ttattggtga tttaaaagaa 120
gaagatgggc agaaagctgt tgcagaaatt aaggcagcag gtggtgaagc cgcatttgtc 180
aaactgaatg taacagatga ggctgcatgg aaagccgcta ttgagcaaac gcttaagctt 240
tatgggcggc tggatattgc agtgaacaat gcaggcattg cgtattctgg cagtgtagaa 300
agcacatctc tggaagattg gcggcgcgtt cagtctatca atctggatgg cgtgtttttg 360
ggcacacagg tggctattga ggccatgaag aagtcgggcg gtggatccat tgtcaatctg 420
tcttccattg aaggactggt aggggaccca atgttggccg cctataacgc cagtaaaggt 480
ggggtaaggc tgtttacaaa atctgcggcc ctacattgcg ccaaatctgg atacaaaatt 540
cgggtaaact cagtgcatcc cggctatatc tggacaccta tggtggccgg tttaacaaag 600
gaagatgctg ctgcacgcca aaagctggtg gatctgcacc ccattggcca cttgggtgag 660
cccaacgata ttgcttacgg tattttgtat cttgcctctg atgaatccaa gtttgttaca 720
gggagcgaac tggtcattga tggtgggtac accgcgcaat aa 762

Claims (4)

1. a kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L), it is characterised in that: its amino acid sequence such as SEQ Shown in ID NO.1.
2. encoding the gene of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) described in claim 1, feature exists In: gene order is as shown in SEQ ID NO.2.
3. carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) according to claim 1, it is characterised in that: by Carbonylation reductase AcCR obtains carbonyl reduction enzyme mutant mut-AcCR (I147V/ by the means that enzyme molecule is mutated G152L)。
4. asymmetry of the carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) in carbonyls described in claim 1 Application in reduction.
CN201811412383.8A 2018-11-25 2018-11-25 Carbonyl reductase mutant mut-AcCR (I147V/G152L) and application and coding gene thereof Active CN109355265B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811412383.8A CN109355265B (en) 2018-11-25 2018-11-25 Carbonyl reductase mutant mut-AcCR (I147V/G152L) and application and coding gene thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811412383.8A CN109355265B (en) 2018-11-25 2018-11-25 Carbonyl reductase mutant mut-AcCR (I147V/G152L) and application and coding gene thereof

Publications (2)

Publication Number Publication Date
CN109355265A true CN109355265A (en) 2019-02-19
CN109355265B CN109355265B (en) 2021-07-20

Family

ID=65338689

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811412383.8A Active CN109355265B (en) 2018-11-25 2018-11-25 Carbonyl reductase mutant mut-AcCR (I147V/G152L) and application and coding gene thereof

Country Status (1)

Country Link
CN (1) CN109355265B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109837254A (en) * 2019-03-28 2019-06-04 中国科学院成都生物研究所 A kind of carbonyl reduction enzyme mutant that thermal stability improves
CN109852592A (en) * 2019-01-14 2019-06-07 中国科学院成都生物研究所 The carbonyl reduction enzyme mutant that heat resistance improves
JP2022536500A (en) * 2019-06-13 2022-08-17 アシムケム ラボラトリーズ (ティエンジン) カンパニー リミテッド Ketoreductase mutants and methods for producing chiral alcohols

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105349503A (en) * 2015-11-30 2016-02-24 华南理工大学 Carbonyl reductase AcCR and encoding gene and application thereof
CN108728421A (en) * 2018-06-19 2018-11-02 中国科学院成都生物研究所 A kind of carbonyl reduction enzyme mutant and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105349503A (en) * 2015-11-30 2016-02-24 华南理工大学 Carbonyl reductase AcCR and encoding gene and application thereof
CN108728421A (en) * 2018-06-19 2018-11-02 中国科学院成都生物研究所 A kind of carbonyl reduction enzyme mutant and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PING WEI等: "Enzymatic characterization of a recombinant carbonyl reductase from Acetobacter sp. CCTCC M209061", 《BIORESOURCES AND BIOPROCESSING》 *
PING WEI等: "Significantly enhancing the biocatalytic synthesis of chiral alcohols by semi-rationally engineering an anti-Prelog carbonyl reductase from Acetobacter sp. CCTCC M209061", 《MOLECULAR CATALYSIS》 *
WEI,P.等: "AWE05150.1", 《GENBANK》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109852592A (en) * 2019-01-14 2019-06-07 中国科学院成都生物研究所 The carbonyl reduction enzyme mutant that heat resistance improves
CN109852592B (en) * 2019-01-14 2022-05-31 中国科学院成都生物研究所 Carbonyl reductase mutant with improved heat resistance
CN109837254A (en) * 2019-03-28 2019-06-04 中国科学院成都生物研究所 A kind of carbonyl reduction enzyme mutant that thermal stability improves
CN109837254B (en) * 2019-03-28 2022-05-31 中国科学院成都生物研究所 Carbonyl reductase mutant with improved thermal stability
JP2022536500A (en) * 2019-06-13 2022-08-17 アシムケム ラボラトリーズ (ティエンジン) カンパニー リミテッド Ketoreductase mutants and methods for producing chiral alcohols
EP3985109A4 (en) * 2019-06-13 2023-02-08 Asymchem Laboratories (Tianjin) Co., Ltd Ketoreductase mutant and method for producing chiral alcohols
JP7375052B2 (en) 2019-06-13 2023-11-07 アシムケム ラボラトリーズ (ティエンジン) カンパニー リミテッド Ketoreductase mutant and method for producing chiral alcohol

Also Published As

Publication number Publication date
CN109355265B (en) 2021-07-20

Similar Documents

Publication Publication Date Title
Watson et al. Unusual ribulose 1, 5-bisphosphate carboxylase/oxygenase of anoxic Archaea
CN109355265A (en) A kind of carbonyl reduction enzyme mutant mut-AcCR (I147V/G152L) and its application and encoding gene
Pereira et al. Structural and biochemical characterization of the early and late enzymes in the lignin β-aryl ether cleavage pathway from Sphingobium sp. SYK-6
CN108728421B (en) Carbonyl reductase mutant and application thereof
CN108070581B (en) L-aspartate beta-decarboxylase mutant with improved enzyme activity and application thereof
CN110777125B (en) Efficient preparation method of heterocyclic drug intermediate
CN106282138A (en) Clostridium sardiniense 7 α hydroxysteroid dehydrogenase mutant T145S
CN107164342A (en) A kind of epoxide hydrolase in Kidney bean source and its application
CN103122355A (en) Recombinant heat resisting aldehyde ketoreductase gene, coding enzyme, vector, engineering bacteria and application
CN108753747B (en) MTSase mutant with improved thermal stability and trehalose yield
WO2023109530A1 (en) Use of oxidoreductase and mutant thereof in biosynthesis of nootkatone
CN102952814A (en) Recombined heat-resisting short-chain dehydrogenase gene, codase, carrier, engineering bacterium and application
CN109468293A (en) A kind of carbonyl reduction enzyme mutant mut-AcCR (E144A/G152L) and its application and encoding gene
CN113337495B (en) Method for improving sialic acid yield and application
Zeng et al. Comparative characterization and physiological function of putative fatty acid photodecarboxylases
CN108034646B (en) PvEH3 mutant with improved catalytic activity and improved enantiotropic normalization
CN109370994A (en) A kind of carbonyl reduction enzyme mutant mut-AcCR (G152L/Y189) and its application and encoding gene
CN107828752B (en) Saccharopolyase, preparation method and application in production of alpha-arbutin
CN113308446B (en) Maltooligosyl trehalose synthase mutant with improved trehalose conversion rate and application thereof
CN106086089A (en) A kind of method that enzyme process asymmetric reduction citral improves (R) citronellal optical purity
CN110004120A (en) A kind of recombination aldehyde Ketoreductase mutant and application
CN114214293A (en) Pseudomonas putida cytochrome P450 epoxidase mutant and application thereof
CN103966185A (en) Double-enzyme system for efficiently synthesizing S-adenosylhomocysteine and application method thereof
CN114507650A (en) Leucine dehydrogenase mutant and application thereof in synthesis of (S) -o-chlorophenylglycine
CN109609473A (en) A kind of carbonyl reductase DmCR and its encoding gene, recombinant expression carrier, recombinant expression cell and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant